Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

PureTech Highlights Deupirfenidone's Ability To Stabilize Lung Function While Maintaining Strong Tolerability In Older Adults With Idiopathic Pulmonary Fibrosis At CHEST 2025 Annual Meeting

Author: Benzinga Newsdesk | October 22, 2025 03:18am

Posted In: PRTC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist